Publications

This is a list of selected publications by Dr. Rebecca Conway.

1. 1. 1. Conway RB, Armistead MG, Denney MJ, Smith GS. Validating matching of patients in the linkage of a large hospital system’s EHR with state and national death databases.  Applied Clinical Informatics 2021; 12(01): 082-089.
      2. Conway RBN, Peltier A, Figaro MK.  Diabetes and Constipation.  J Diab Comp 2021; 35 (2): 107799.
      3. Conway RB, Sudenga S, McClain D, Blot WJ.  Diabetes and Liver Cancer Risk: a stronger effect in Whites than Blacks?  J Diab Comp 2020.  Online ahead of print: Dec 1, 2020. doi: 10.1016/j.jdiacomp.2020.107816
      4. Tomaszewski EL, Orchard TJ, Hawkins M, Conway BN, Buchanich JM, Maynard J, Songer T, Costacou T.  Skin intrinsic fluorescence scores are a predictor of all-cause mortality risk in type 1 diabetes: The Epidemiology of Diabetes Complications Study.  J Diab Comp 2021;35(2):107770.  doi: 10.1016/j.jdiacomp.2020.107770.
      5. Figaro MK, Long DM, May ME, Ndetan H, Cook A, Conway RB.  Racial Variation in the Relationship of Glycemic Control with Fracture Risk in Elderly Patients with Diabetes.  Diabetes Metabolic Syndrome and Obesity: Targets and Therapy 2020; 13: 4153-4155.
      6. Tomaszewski E, Orchard T, Hawkins M, Conway B, Buchanich J, Maynard J, Songer T, Costacou T.  Predictors of change in skin intrinsic fluorescence in type 1 diabetes: The Epidemiology of Diabetes Complications study.  Journal of Diabetes Science and Technology 2020.  In Press.
      7. Hutcheson R, Innes K, Conway B.  Perfluoroalkyl Substances and Likelihood of Stroke in Persons with and without Diabetes.  Diabetes and Vascular Disease Research 2020. Jan-Feb 2020;17(1):1479164119892223.
      8. Honda-Kohmo K, Hutcheson R, Innes KE, Conway BN.  Perfluoroalkyl Substances are Inversely Associated with Coronary Heart Disease in Adults with Diabetes.  Journal of Diabetes and Its Complications 2019; 33(6): 407-412.
      9. Conway BN, Badders AN, Costacou T, Arthur JM, Innes KE.  Perfluoroalkyl Substances and Kidney Function in Chronic Kidney Disease, Anemia and Diabetes.  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018; 11:707-716.
      10. George C, Ducatman AM, Conway B.  Increased Risk of Respiratory Diseases in Adults with Type 1 and Type 2 Diabetes.  Diabetes Research and Clinical Practice 2018; 142: 46-55.
      11. Conway B, Lopes-Virella M, Blot W.  Late Adulthood Mortality among Black and White Survivors of Type 1 Diabetes by Age at Diabetes Diagnosis.  Diabetic Medicine 2018; 35 (6): 729-736.  doi: 10.1111/dme.13617.
      12. Conway B, Han X, Munro H, Gross A, Shu X-O, Hargreaves M, Zeng W, Powers A, Blot W.  The obesity epidemic and rising diabetes incidence in a low-income racially diverse US cohort.  PLoS One 2018; 13 (1); e0190993.
      13. Williams A, Conway B.  Effect of High Density Lipoprotein Cholesterol on the Relationship of Serum Iron and Hemoglobin with Kidney Function in Diabetes.  Journal of Diabetes and Its Complications 2017; 31 (6): 958-963.
      14. . Conway B, Bot W.  Letter to the Editor of Circulation in response to: “Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus”.  American Heart Association website: Guidelines and Statements.  http://professional.heart.org/professional/GuidelinesStatements/Correspondence/UCM_320919_Correspondence.jsp  August 18, 2016.
      15. Denney MJ, Long DM, Armistead MG, Anderson JL, Conway BN.  Validating the Extract, Transform, Load Process Used to Populate a Large Clinical Research Database.  International Journal of Medical Informatics. 2016; 94: 271-274.
      16. Williams A, LaSala PR, Conway B.  Case Study Investigating Two Cases of Neonatal Salmonellosis.  Clinical Case Reports and Reviews 2016; DOI: 10.15761/CCRR.1000240.
      17. Conway B, Innes K, Long D.  Perfluoroalkyl Substances and Beta Cell Deficient Diabetes.  Journal of Diabetes and Its Complications 2016; 30 (6): 993-998.
      18. Conway B, Long D, Figaro MK, May ME.  Glycemic Control and Fracture Risk in Elderly Patients with Diabetes.  Diabetes Research and Clinical Practice. 2016; 115: 47-53.
      19. Dodd K, Murray PJ, Fischl A, Costacou T, Conway B.  Overweight, Obesity, Perfluorooctanoic Acid Exposure and Cardiovascular Risk Factors in an Appalachian Pediatric Population with Diabetes.  Jacobs Journal of Obesity. 2016; 2 (1): 025.
      20. Conway BN, May ME, Fischl A, Frisbee J, Blot WJ.  Cause-specific Mortality in Low-income African Americans and Whites with Type 2 Diabetes.  Diabetic Medicine 2015; 32: 33-41.
      21. Weber K*, Fischl AF, Murray PJ, Conway BN.  Effect of BMI on Cardiovascular and Metabolic Syndrome Risk Factors in an Appalachian Pediatric Population.  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014; 7:445-453.
      22. Alshaarawy O*, Zhu M, Ducatman AM, Conway B, Andrew ME.  Urinary Polycyclic Aromatic Hydrocarbon Biomarkers and Diabetes Mellitus.  Occupational and Environmental Medicine.  2014; 71 (6):437-441.
      23. Alshaarawy O*, Zhu M, Ducatman A, Conway B, Andrew M.  Polycyclic Aromatic Hydrocarbon Biomarkers and Serum Markers of Inflammation. A Positive Association that is more Evident in Men.  Environmental Research 2013; 126: 98-104.
      24. Conway BN, Elasy TA, May ME, Blot WJ.  Mortality by Race among Low-income Adults with Early-onset Insulin-treated Diabetes.  Diabetes Care 2013; 36 (10):3107-3112.
      25. Conway B, Peltier A.  Diabetic Neuropathy.  In Escher AP, Li A (Eds), Type 1 Diabetes 2013.  InTech: Rijeka, Croatia.  ISBN:  980-953-307-711-1.
      26. Aroda VR, Conway BN, Fernandez SJ, Matter NI, Maynard JD, Orchard TJ, Ratner RE.  Cross-Sectional Evaluation of Noninvasively-Detected Skin Intrinsic Fluorescence and Mean Hemoglobin A1c in Type 1 Diabetes.  Diabetes Technology and Therapeutics 2013; 15 (2): 117-123.
      27. Conway BN, Aroda VR, Maynard JD, Matter N, Fernandez S, Ratner RE, Orchard TJ.  Skin Intrinsic Fluorescence is Associated with Coronary Artery Disease in Individuals with Long Duration of Type 1 Diabetes.  Diabetes Care 2012; 35 (11): 2331-2336.
      28. Conway BN, May ME, Blot WJ.  Mortality among Low-income African Americans and Whites with Diabetes.  Diabetes Care 2012; 35 (11): 2293-2299.
      29. Conway BN.  Comment on: Elevated Transferrin Saturation and Risk of Diabetes: Three population-based studies.  Diabetes Care 2012; 7(3): e30625.
      30. Conway B, Shu X-O, Zhang X, Xiang Y-B, Cai H, Li H, Yang G, Gao Y-T, Zheng W.  Age at Menarche, the Leg Length to Sitting Height Ratio, and Risk of Diabetes in Middle-Aged and Elderly Chinese Men and Women.  PLoS ONE 2012;7 (3):e30625.
      31. Conway BN, May ME, Signorello LB, Blot WJ.  The Mortality Experience of a Low Income Population with Young-Onset Diabetes.  Diabetes Care 2012; 35 (3):542-548.
      32. Conway B, Maynard J, Orchard T.  Comment on: Sun et al. Protection from Retinopathy and other Complications in Patients with Type 1 Diabetes of Extreme Duration: the Joslin 50-year Medalist Study.  Diabetes Care 2011; 34:968–974.
      33. Conway B, Xiang Y-B,  Villegas R,  Zhang X, Li H,  Wu X,  Yang G,  Gao Y-T, Zhang W, Shu X-O.  Hip Circumference and the Risk of Type 2 Diabetes in Middle-aged and Elderly Men and Women: the Shanghai Women and Shanghai Men’s Health Studies.  Annals of Epidemiology 2011; 21 (5): 358-366.
      34. Conway BN, Aroda VR, Maynard JD, Matter N, Fernandez S, Ratner RE, Orchard TJ.  Skin Intrinsic Fluorescence Correlates with Autonomic and Distal Symmetrical Polyneuropathy in Individuals with Type 1 Diabetes.  Diabetes Care 2011; 34 (4):1000-1005.
      35. Conway B, Matter N, Maynard J, Edmundowicz D, Orchard T.  Skin Fluorescence Correlates Strongly with Coronary Artery Calcification Severity in Type 1 Diabetes.  Diabetes Technology and Therapeutics 2010; 12(5): 339-345.
      36. Conway B, Miller R, Costacou T, Fried L, Kelsey S, Evans R, Orchard T.  Temporal Patterns in Overweight and Obesity in Type 1 Diabetes.  Diabetic Medicine 2010; 27(4):398-404.
      37. Conway B, Miller R, Orchard T.  Are Hemoglobin Levels Elevated in Type 1 Diabetes?  Diabetes Care 2010; 33(2): 341-343.
      38. Conway B, Miller R, Klein R, Orchard T.  Prediction of Proliferative Diabetic Retinopathy with Hemoglobin Level.  Archives of Ophthalmology 2009; 127:1494-1499.
      39. Conway B, Evans R, Fried L, Kelsey S, Edmundowicz D, Orchard T.  Free Fatty Acids are Associated with Pulse Pressure in Women, but not Men, with Type 1 Diabetes.  Metabolism 2009; 58 (9):1215-1221.
      40. Conway B, Miller R, Costacou T, Fried L, Kelsey S, Evans R, Orchard T.  Adiposity and Mortality in Type 1 Diabetes.  International Journal of Obesity 2009; 33 (7):796-805.
      41. Conway B, Costacou T, Orchard T.  Is Glycaemia or Insulin Dose the Stronger Risk Factor for Coronary Artery Disease (CAD) in Type 1 Diabetes?  Diabetes and Vascular Disease Research 2009; 6 (4):223-230.
      42. Conway B, Fried L, Orchard T.  Hemoglobin and Overt Nephropathy Complications in Type 1 Diabetes.  Annals of Epidemiology 2008; 18 (2):147-155.
      43. Conway B, Miller R, Costacou T, Fried L, Kelsey S, Evans R, Edmundowicz D, Orchard T.  Double Edged Relationship of Adiposity with Coronary Artery Calcification in Type 1 Diabetes.  Diabetes and Vascular Disease Research 2007; 4:332-339.
      44. Costacou T, Edmundowicz D, Prince CT, Conway B, Orchard TJ.  Progression of coronary artery calcification in type 1 diabetes.  American Journal of Cardiology 2007; 100(10):1543-1547.
      45. Conway B and Rene A.  Obesity as a disease: no light-weight matter.  Obesity Reviews 2004; 5(3):145-151.